Literature DB >> 16372400

Cancer.

Adda Grimberg1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16372400      PMCID： PMC4149339          DOI： 10.1007/0-387-26274-1_13

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  186 in total

1.  Leukaemia in patients treated with growth hormone.

Authors: 
Journal:  Lancet       Date:  1988-05-21       Impact factor: 79.321

2.  Growth enhancement of transgenic mice expressing human insulin-like growth factor I.

Authors:  L S Mathews; R E Hammer; R R Behringer; A J D'Ercole; G I Bell; R L Brinster; R D Palmiter
Journal:  Endocrinology       Date:  1988-12       Impact factor: 4.736

3.  Cyclic AMP induces insulin-like growth factor I synthesis in osteoblast-enriched cultures.

Authors:  T L McCarthy; M Centrella; E Canalis
Journal:  J Biol Chem       Date:  1990-09-15       Impact factor: 5.157

4.  Functional interactions between colony-stimulating factors and the insulin family hormones for human myeloid leukemic cells.

Authors:  D Oksenberg; B S Dieckmann; P L Greenberg
Journal:  Cancer Res       Date:  1990-10-15       Impact factor: 12.701

5.  Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma.

Authors:  P Cohen; H C Graves; D M Peehl; M Kamarei; L C Giudice; R G Rosenfeld
Journal:  J Clin Endocrinol Metab       Date:  1992-10       Impact factor: 5.958

6.  Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity.

Authors:  M A Soos; C E Field; K Siddle
Journal:  Biochem J       Date:  1993-03-01       Impact factor: 3.857

Review 7.  Structure, evolution, expression and regulation of insulin-like growth factors I and II.

Authors:  P Rotwein
Journal:  Growth Factors       Date:  1991       Impact factor: 2.511

8.  Growth hormone promotes early initiation of hepatocyte growth factor gene expression in the liver of hypophysectomized rats after partial hepatectomy.

Authors:  S Ekberg; M Luther; T Nakamura; J O Jansson
Journal:  J Endocrinol       Date:  1992-10       Impact factor: 4.286

9.  Histopathology associated with elevated levels of growth hormone and insulin-like growth factor I in transgenic mice.

Authors:  C J Quaife; L S Mathews; C A Pinkert; R E Hammer; R L Brinster; R D Palmiter
Journal:  Endocrinology       Date:  1989-01       Impact factor: 4.736

10.  Premature mortality due to cardiovascular disease in hypopituitarism.

Authors:  T Rosén; B A Bengtsson
Journal:  Lancet       Date:  1990-08-04       Impact factor: 79.321
View more
  4 in total

Review 1.  Risk of Neoplasia in Pediatric Patients Receiving Growth Hormone Therapy--A Report From the Pediatric Endocrine Society Drug and Therapeutics Committee.

Authors:  Sripriya Raman; Adda Grimberg; Steven G Waguespack; Bradley S Miller; Charles A Sklar; Lillian R Meacham; Briana C Patterson
Journal:  J Clin Endocrinol Metab       Date:  2015-04-03       Impact factor: 5.958

Review 2.  Pediatric brain tumor treatment: growth consequences and their management.

Authors:  Sogol Mostoufi-Moab; Adda Grimberg
Journal:  Pediatr Endocrinol Rev       Date:  2010-09

3.  POTENTIAL NON-GROWTH USES OF rhIGF-I.

Authors:  Roy J Kim; Adda Grimberg
Journal:  Growth Genet Horm       Date:  2007-03

4.  Insulin-like growth factor factor binding protein-2 is a novel mediator of p53 inhibition of insulin-like growth factor signaling.

Authors:  Adda Grimberg; Carrie M Coleman; Zonggao Shi; Timothy F Burns; Timothy K MacLachlan; Wenge Wang; Wafik S El-Deiry
Journal:  Cancer Biol Ther       Date:  2006-10-30       Impact factor: 4.742
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.